DrugRepV Browse Page

DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for NR assay are 38

DrugRepV_ID	Antiviral Name	Drug type	Primary Indication	Secondary Indication	Strain	Pathways	Assay	Activity	Clinical Status	References
DrugRepV_7434	6-Azauridine	NA	Cancer	West Nile virus	New York		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7435	6-Azauridine	NA	Cancer	West Nile virus	Uganda strain B 956		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7436	6-Azauridine triacetate	NA	NA	West Nile virus	New York		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7437	6-Azauridine triacetate	NA	NA	West Nile virus	Uganda strain B 956		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7438	Pyrazofurin	NA	NA	West Nile virus	New York		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7439	Pyrazofurin	NA	NA	West Nile virus	Uganda strain B 956		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7440	2-Thio-6-azauridine	NA	NA	West Nile virus	New York		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7441	2-Thio-6-azauridine	NA	NA	West Nile virus	Uganda strain B 956		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7454	3-Deazaguanosine	NA	NA	West Nile virus	New York		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7455	Mycophenolic Acid	Antineoplastic and Immunomodulating Agents	Organ rejection (immunosuppressants)	West Nile virus	New York		NR assay	Decrease (50 %)	Approved	12076755
DrugRepV_7456	Mycophenolic Acid	Antineoplastic and Immunomodulating Agents	Organ rejection (immunosuppressants)	West Nile virus	Uganda strain B 956		NR assay	Decrease (50 %)	Approved	12076755
DrugRepV_7457	Ribamidine	NA	NA	West Nile virus	New York		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7458	Ribamidine	NA	NA	West Nile virus	Uganda strain B 956		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7459	Ribavirin	Antiinfectives For Systemic Use	Hepatitis C virus	West Nile virus	New York		NR assay	Decrease (50 %)	Approved	12076755
DrugRepV_7460	Ribavirin	Antiinfectives For Systemic Use	Hepatitis C virus	West Nile virus	Uganda strain B 956		NR assay	Decrease (50 %)	Approved	12076755
DrugRepV_7461	Selenazofurin	NA	NA	West Nile virus	New York		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7462	Selenazofurin	NA	NA	West Nile virus	Uganda strain B 956		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7463	Tiazofurin	Antineoplastic and Immunomodulating Agents	Cancer	West Nile virus	New York		NR assay	Decrease (50 %)	Experimental	12076755
DrugRepV_7464	beta-Methylene TAD	NA	NA	West Nile virus	New York		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7465	beta-Methylene TAD	NA	NA	West Nile virus	Uganda strain B 956		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7470	3-Deazauridine	NA	NA	West Nile virus	New York		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7471	3-Deazauridine	NA	NA	West Nile virus	Uganda strain B 956		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7472	Cyclopentenylcytosine	NA	NA	West Nile virus	New York		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7473	Cyclopentenylcytosine	NA	NA	West Nile virus	Uganda strain B 956		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7477	Hypericin	Anticancer	Cutaneous T-cell Lymphoma	West Nile virus	New York		NR assay	Decrease (50 %)	Investigational	12076755
DrugRepV_7478	Suramin	Antiparasitic products, Insectisides and Repellents	Sleeping sickness | Onchocerciasis	West Nile virus	New York		NR assay	Decrease (50 %)	Investigational	12076755
DrugRepV_7479	Suramin	Antiparasitic products, Insectisides and Repellents	Sleeping sickness | Onchocerciasis	West Nile virus	Uganda strain B 956		NR assay	Decrease (50 %)	Investigational	12076755
DrugRepV_7481	5-fluorouridine	NA	Cancer	West Nile virus	New York		NR assay	Decrease (50 %)	Experimental	12076755
DrugRepV_7485	(S )-DHPA	NA	NA	West Nile virus	New York		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7486	(S )-DHPA	NA	NA	West Nile virus	Uganda strain B 956		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7487	3-Deazaneplanocin A	NA	NA	West Nile virus	New York		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7490	6-Bromotoyocamycin	NA	NA	West Nile virus	New York		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7491	Formycin B	NA	NA	West Nile virus	New York		NR assay	Decrease (50 %)	Experimental	12076755
DrugRepV_7497	2-Thiouracil	NA	NA	West Nile virus	New York		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7498	5-Azacytidine	Antineoplastic and Immunomodulating Agents	Anemia	West Nile virus	New York		NR assay	Decrease (50 %)	Approved	12076755
DrugRepV_7499	Cyclopentyluracil	NA	NA	West Nile virus	New York		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7500	Dihydro-5-azacytidine	NA	NA	West Nile virus	New York		NR assay	Decrease (50 %)	NA	12076755
DrugRepV_7501	Uridine 2,3-dialdehyde	NA	NA	West Nile virus	New York		NR assay	Decrease (50 %)	NA	12076755